Furthermore, a Chinese study on patients with an acute MI with a ST-elevation (STEMI) demonstrated statistically significant, 2 times higher YKL-40 concentrations in STEMI patients compared to controls, arguing for YKL-40 as a potential biomarker for STEMI diagnosis (63). This evidence concerns the gene CHI3L1 and myocardial infarction.